• PBM Resources
• Legislative Defense Fund
• NCPA PAC

• About Membership
• Benefits
• Categories
• Multiple Locations
• Corporate Membership
• Members Only

• NCPA's Blog— The Dose
• Press Releases
• NCPA Commentary
• Other Resources
• Photos
• Videos
• America's Pharmacist
• eNews Weekly Archives

• Government Affairs
• Legal Proceedings
• LDF
• NCPA PAC
• PBM Resources
• Legislative Action Network

• 2010 Convention
• DASPA
• 2010 Legislative Conference
• Jumpstart
• 2009 Convention
• Ownership Workshop
• 2008 Convention
• Video Library
• Photo Galleries

• Students
• Pre-Buyers
• Buyers
• Owners
• Sellers
• Practice Tools
• Community CCRx
• Professional Development

• Leadership
• Business Plan Competition
• Ownership
• Internships
• Resources
• Scholarships

Legislative and Government Affairs

CCPA |   Congressional Letters in Support of Pharmacy |   CPSIA   |   DEA  
DME   |   FDA   |   HIT/Privacy   |   Medicaid Pharmacy Reiumbursement   |   Medication Disposal
Medicare Part D   |   MTM   |  NCPA Letters in Support of Community Pharmacy  |  
Negotiation Rights for Independent Community Pharmacies
TRICARE    |   Video Updates

Comments Filed on Behalf of Community Pharmacy

• NCPA Comments to CMS regarding Payment Policies Under the Physician Fee Schedule and Other Revisions to Part B for CY 2011 8-24-2010 (81k)
   
• NCPA Comments to HHS Office of Consumer Information and Insurance Oversight Regarding an Interim Final Rule for Group Health Plans (GHP) 8-13-2010 (156k)
   
• Statement Regarding FDA Class-Wide Opioid Risk Evaluation and Mitigation Strategies 7-23-2010 (18k)
   

Congressional Letters in Support of Pharmacy

 

• Senator Cochran Letter to Agency for Healthcare Research and Quality Regarding MTM 6-14-2010 (61k)
   
• Letter from Representatives Tammy Baldwin and Bart Stupak to CMS Regarding Medicare Part B DME MAC Excessive Recoupment Activity 6-14-2010 (926k)
   
• Letter from Representatives Halvorson and Hare to Caterpillar 6-9-2010 (363k)
   
• Representatives Engel and Baldwin Letter to FTC Regarding Ranbaxy's Denial of Supply of Valacyclovir 6-3-2010 (88k)
   

CPSIA

• The Consumer Product Safety Improvement Act and New Requirements for Community Pharmacies (34k)
   
• List of Affected Products PDF (17k)
   

DEA

• Department of Justice Drug Enforcement Administration Office of Diversion Control's Electronic Prescriptions for Controlled Substances Q&A
  
   
• Information from the Department of Justice Drug Enforcement Administration Office of Diversion Control Regarding Electronic Prescriptions for Controlled Substances
  
   
• NCPA Letter to DEA Regarding Electronic Prescriptions for Controlled Substances 6-1-10 PDF (63k)
  
   
• Joint Letter from Multiple Pharmacy Organizations to DEA Regarding Electronic Prescriptions for Controlled Substances 6-1-10 PDF (116k)
  
   
• NCPA Letter to DEA Regarding 21 CFR Part 1301 [Docket no. DEA-321a] Identification of Institution-based Individual Practitioners 9-9-09 PDF (96k)
   

Durable Medical Equipment

• CMS Fact Sheet Discussing the Changes the Patient Protection and Affordable Care Act (PPACA) made to the Medicare Improvements for Patients and Providers Act (MIPPA)
   
• CMS-6010-IFC; Medicare and Medicaid Programs; Changes in Provider and Supplier Enrollment, Ordering and Referring, and Documentation Requirements; and Changes in Provider Agreements PDF (56k)
   
• Guidance on Implementing Section 3109 (a) of the Patient Protection and Affordable Care Act (PPACA) 6-25-10 PDF (245k)
   
• NACDS, NASPA, and NCPA Letter to CMS Regarding DME MAC Medicare Part B Overpayment Recovery Demand Letters 2-3-10 PDF (300k)
   
• Medicare's New Competitive Acquisition Program for Durable Medical Equipment: Policy Considerations Involving Beneficiaries with Diabetes, Community-Based Retail Pharmacies and Blood Glucose Monitoring PDF (249k)
   

FDA

• Comments Submitted to FDA Regarding Reopening of Comment Period for Risk Evaluation and Mitigation Strategies (REMS) 8-31-10 PDF (114k)
   
• Comments Submitted to FDA Regarding Risk Evaluation and Mitigation Strategies (REMS) 12-30-09 PDF (114k)
   
• Comments Submitted to FDA Regarding Written Drug Information Provided to Consumers 11-25-09 PDF (103k)
   
• Comments Submitted to FDA 2010-N-0184 Experimental Study of Patient Information Prototypes PDF (93k)
   
• Comments Submitted to FDA Regarding Long Acting Opioid Risk Evaluation and Mitigation Strategies 7-28-10 PDF (44k)
   

HIT/Privacy

• NCPA Letter to HHS Regarding Document ID: RIN 0991-AB62, HIPAA Privacy Rule Accounting of Disclosures under the Health Information Technology for Economic and Clinical Health Act; Request for Information [45 CFR Parts 160 and 164] 5-18-10 PDF (190k)
   
• Comments to CMS and ONC From Multiple Organizations Regarding Medication Reconciliation and the Role of Pharmacists in Relation to Meaningful Use 3-15-10 PDF (96k)
   
• APHA and NCPA Comments to CMS and ONC Regarding Medication Reconciliation and the Role of Pharmacists in Relation to Meaningful Use and EHRS 3-15-10 PDF (61k)
   
• Summary and Analysis of CMS and ONC Proposed Rules on Electronic Health Records and Meaningful Use 3-11-10 PDF (139k)
   
• Joint Letter to HHS and FTC Regarding CVS Caremark Egregious Disregard of Protected Healthcare Information 11-20-09 PDF (352k)
   
• NCPA Comments to HHS Regarding Breach Notification Interim Final Rule 10-23-09 PDF (62k)
   
• HIT and the Recovery and Reinvestment Act of 2009: A Roadmap for Community Pharmacy Proceedings and Environmental Scan PDF (352k)
   

Medicaid Pharmacy Reiumbursement

• NCPA Letter Regarding the Alabama SPA Changing Medicaid Pharmacy Reimbursement 6-21-10 PDF (107k)

Medicare Part D

• NCPA Comments to CMS Regarding Medicare Coverage Gap Discount Program Model Manufacturer Agreement 6-21-10 PDF (53k)
   
• Walter Jones and Marion Berry Letter to CMS Regarding Certain Medicare Part D Plans Circumventing Intent of Prompt Pay Law 6-3-10 PDF (716k)
   
• CMS Reminder to Fox Insurance of Fox's Obligation to Pay Claims with Dates of Service Prior to the Termination of its Contract 5-17-10 PDF (151k)
   
• NCPA Comments to CMS Regarding Medicare Coverage Gap Discount Program beginning in 2011 5-14-10 PDF (117k)
   
• Kaiser Foundation - Key Changes to the Medicare Part D Drug Benefit Coverage Gap 3-26-10 PDF (209k)
   
• NCPA Letter to CMS Regarding Certain Medicare Part D Plans Circumventing Intent of Prompt Pay Law 3-4-10 PDF (33k)
   
• 2011 Medicare Part D Draft Call Letter 3-5-10 PDF (118k)
   
• Letter to CMS Regarding the Medicare Parts C and D proposed rule 12-8-09 PDF (181k)
   
• CMS Provides Clarifications on Medicare Part D Fraud, Waste and Abuse Training 10-6-09 PDF (163k)
   

Medication Disposal

• Cheri Garvin Statement at US House of Representatives Committee on the Judiciary on Secure and Responsible Drug Disposal Hearing 6-18-09 PDF (98k)

Medication Therapy Management (MTM)

• MTM Frequently Asked Questions 3-11-09 PDF (94k)

NCPA Letters in Support of Community Pharmacy

• Impact of Potential Changes in Mail Service on Prescription Medication Availability 7-12-10
   

Negotiation Rights for Independent Community Pharmacies

• H.R. 1204: The Community Pharmacy Act of 2008
   

TRICARE

• NCPA Comments to DoD Regarding the TRICARE Program and the Extension of Federal Ceiling Prices to Retail Pharmacy Prescriptions 3-11-10 PDF (109k)
   
• NCPA Comments to DoD Regarding Expanding Coverage to Additional Vaccines that RPh Can Administer via the TRICARE Program 2-8-10 PDF (109k)
   

Video Updates

• NCPA Senior Vice President John Coster's Updates on NCPA's Legislative Activities
   

CONGRESSIONAL COMMUNITY PHARMACY COALITION

• Fact Sheet about the Congressional Community Pharmacy Coalition PDF (32k)
   
• Membership Roster 2/2/10 for the Congressional Community Pharmacy Coalition PDF (61k)